Schedule 13D ownership disclosure

LogicBio Therapeutics, Inc.

Security class unavailable · CUSIP: 54142F102

Event date: 2018-10-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
12.9600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-18-000868
Form type
SC 13D
Filer
LogicBio Therapeutics, Inc.
CIK
CIK 1664106
Filed
Nov 01, 2018
Reporting period
Oct 23, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub